🔴
Trending
- Here are some reasons why this unpopular stock market technique might work now that trade agreements are being finalized.
- How Bessent clarified the euphoric market reaction to the 115-point drop in U.S.-China tariffs
- This is the difference in weight loss between Zepbound and Wegovy.
- Trump’s announcement that he will issue an executive order to reduce the cost of prescription drugs has put pressure on pharmaceutical stocks.
- This week marks the release of the “most important consumer earnings report of the season.”
- Goldman Sachs warns that stocks might collapse by about 20%. This is the trigger.
- The majority of American businesses may be impacted by Trump’s proposal to raise taxes on affluent Americans.
- Even if the trade conflict fades, Hartnett of Bank of America remains concerned about stocks at the start of the year.
